Wolfe Research analyst Alexandria Hammond initiated coverage of Moderna (MRNA) with an Underperform rating and $40 price target Moderna may ...

Wolfe Research initiated coverage of Regeneron (REGN) with an Outperform rating and $1,150 price target Eylea patent litigation concerns had ...

Fintel reports that on November 14, 2024, Wolfe Research initiated coverage of Maravai LifeSciences Holdings (NasdaqGS:MRVI) ...

If you want consistent income, look to consistent dividend payers. These three stocks are some of the best in the business ...

Both of these Canadian stocks have proven to be solid long-term buys, but which is better for the average investor?

On Wednesday, RLJ Lodging Trust (RLJ) stock saw a modest uptick, ending the day at $10.01 which represents a slight increase of $0.07 or 0.70% from the prior close of $9.94. The stock opened at $9.96 ...

State medical boards aren't doing enough to discipline potentially dangerous doctors, according to a report from Public ...

Fintel reports that on November 13, 2024, Wolfe Research upgraded their outlook for Phillips Edison (NasdaqGS:PECO) from Peer ...

Voters really don't like inflation. In fact, whenever there's a sustained jump in the cost of living, the party in power ...

Bank stocks largely boosted the Dow, as investors hope the sector could see weaker regulation in a second Trump ...

Wolfe Research upgrades Warner Bros. Discovery to peer perform, citing potential for stable EBITDA and debt reduction through ...

Investing.com - Wolfe Research has upgraded shares of Warner Bros. Discovery (NASDAQ: NASDAQ: WBD) to Peer Perform from ...